The group's state-of-the-art manufacturing infrastructure is spread across the five states Gujarat, Maharashtra, Goa, Hima-chal Pradesh and Sikkim.Chemical Weekly groupChemical Weekly
“We are happy that our efforts to discover and develop a novel drug for patients living with NASH, an unmet healthcare need globally have been successful,” said Pankaj Patel (pictured left), chairman of Zydus Group. “Saroglitazar will provide hope and new lease of life for millions o...
Zydus group said, “We have always been committed to working with partners and collaborating to bring affordable therapies and bridge unmet healthcare needs. By working with Takeda on this very important research and development initiative and leveraging our development capabilities, we will be taking...
Ibrutinib belongs to a class of drugs known as kinase inhibitors and is used to treat certain cancers, such as mantle cell lymphoma or marginal zone lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, and Waldenstrom's macroglobulinemia. The drug will be manufactured at the group's f...
Brexpiprazole is an atypical antipsychotic indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) and for treatment of schizophrenia. The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad. ...
Speaking about this key development, Mr. Pankaj R. Patel, Chairman and Managing Director, Zydus group said, “We have always been committed to working with partners and collaborating to bring affordable therapies and bridge unmet healthcare needs. By working with Takeda on this very important rese...
The drug is used to treat high blood pressure and urinary retention associated with benign prostatic hyperplasia, it added.Chemical Weekly groupChemical Weekly
Cadila Healthcare Limited, under the aegis of the Zydus group was lead by Patels. During the time, as a WTO treaty signatory, Indian patent regime changed which compelled Indian pharmaceuticals to redefine strategies if one would like to survive and grow. Zydus had proven expertise in ...
The aim of the collaboration is to provide an effective alternative to the current front-line antimalarial drugs for the treatment of uncomplicated P. falciparum malaria, artemisinin-based combination therapies (ACTs), which are under threat of resistance.Chemical Weekly groupChemical Weekly...
Zydus Cadila gets US nod for anti-depressant drugZydus Cadila has received approval from the US-FDA to market Bupropion Hydrochloride extended-release tablets (300 mg), an anti-depressant medicine, in the American market.Chemical Weekly group...